Secondary Offering
Quick Definition
A secondary offering is the sale of shares in a publicly traded company that occurs after the company's initial public offering (IPO). There are two types with very different implications: a primary offering (often misleadingly called a secondary offering) creates new shares and raises money for the company, diluting existing shareholders. A secondary sale involves existing shareholders (insiders, private equity firms) selling shares they already own, and the company receives no proceeds. Both are commonly called "secondary offerings" but their impact on shareholders differs significantly.
What It Means
After a company goes public via IPO, the need to raise additional capital does not end. A company may need money for acquisitions, debt repayment, capital expenditures, or working capital. Major shareholders, including founders, venture capital firms, and private equity sponsors, may also want to convert their equity stakes into cash. Both situations require selling additional shares on the public market.
The market reaction to secondary offerings depends heavily on context:
- A company raising capital for a compelling growth opportunity: often neutral to positive
- A company raising capital from a position of financial weakness: negative signal
- Insiders and PE firms cashing out: can be negative (they are selling for a reason) or neutral (planned distribution)
Understanding which type of secondary offering is occurring, and why, is critical for existing shareholders evaluating whether to hold, buy, or sell.
Types of Secondary Offerings
1. Dilutive Secondary Offering (Primary Offering / Follow-On)
The company issues new shares directly to investors.
- Company receives the proceeds
- Existing shareholders are diluted. Their ownership percentage decreases.
- More shares outstanding means lower earnings per share (all else equal)
- Also called a "follow-on offering" or "seasoned equity offering (SEO)"
Example: A biotech company with 100 million shares outstanding issues 20 million new shares at $25. The company raises $500 million for its drug pipeline. Existing shareholders now own a smaller percentage of the company (diluted by about 17%).
2. Non-Dilutive Secondary Offering (Secondary Sale)
Existing shareholders sell shares they already own to new investors.
- Company receives no proceeds. Money goes to selling shareholders.
- Existing shareholders are not diluted. Share count stays the same.
- Signals insiders want to realize gains or distribute proceeds (PE sponsor exit)
- Also called a "registered direct" or "block trade" when done without a roadshow
Example: The private equity firm that funded a company pre-IPO sells 15 million of its shares at $30. The company's share count remains unchanged. The PE firm receives $450 million. The company sees no benefit.
3. Mixed Offering
A combination of both. The company issues some new shares and existing shareholders sell some of their shares simultaneously.
The Dilution Impact: Worked Example
Company XYZ before secondary offering:
| Metric | Value |
|---|---|
| Shares outstanding | 100 million |
| Share price | $40 |
| Market cap | $4 billion |
| Net income | $200 million |
| Earnings per share (EPS) | $2.00 |
Company issues 10 million new shares at $40 (dilutive secondary):
| Metric | After Secondary |
|---|---|
| Shares outstanding | 110 million (+10%) |
| Market cap (at $40) | $4.4 billion |
| Capital raised | $400 million |
| Net income (unchanged) | $200 million |
| New EPS | $1.82 (diluted by about 9%) |
The 10% share count increase diluted EPS by about 9%. If the $400M raised generates returns above the dilution cost (earnings growth), the offering is value-accretive over time. If not, shareholders are permanently worse off.
Why Companies Do Secondary Offerings
| Reason | Type | Market Signal |
|---|---|---|
| Fund acquisitions | Dilutive | Neutral to positive (if deal is compelling) |
| Pay down debt | Dilutive | Positive (reduces financial risk) |
| Fund expansion/capex | Dilutive | Positive (if growth opportunity is clear) |
| Emergency capital raise | Dilutive | Negative (company in trouble) |
| PE sponsor exit | Non-dilutive | Moderately negative (insider selling) |
| Founder liquidity | Non-dilutive | Negative (often signals reduced conviction) |
| Index inclusion preparation | Dilutive | Neutral |
How Secondary Offerings Are Executed
Overnight (Bought Deal / Block Trade)
The most common method for well-known companies:
- Investment bank contacts the company or selling shareholders
- Bank agrees to buy the entire offering at a set price (typically a 3-7% discount to current price)
- Bank sells shares to institutional investors overnight
- Announced after market close; shares begin trading at new price next morning
- Fast (1 day); minimal price discovery risk
Marketed (Roadshow) Deal
Used for larger offerings or when the company wants to build demand:
- Company files registration statement with the SEC
- Management teams conduct 3-5 day roadshow to institutional investors
- Bank builds a book of demand; prices the offering
- Shares issued and trading begins
- Slower (1-2 weeks); better price discovery
ATM (At-the-Market) Offering
A continuous offering mechanism:
- Company registers a pool of shares with the SEC
- Sells shares gradually into the open market over days, weeks, or months
- Minimal market impact per day; no single large block
- Popular with REITs, smaller companies, and those needing steady capital
- The price is whatever the market price is on each day of selling
Rights Offering
Existing shareholders receive the right to buy new shares at a discount (pro rata to their holdings):
- Company offers existing shareholders the right to maintain their ownership percentage
- Shareholders can exercise (buy more at the discounted price) or sell their rights
- Protects existing shareholders from dilution if they participate
- Common in financial distress situations and in international markets
How the Market Reacts
Typical Price Impact
| Offering Type | Typical Initial Price Reaction |
|---|---|
| Dilutive (strong company, clear use of proceeds) | -3% to -7% (discount to price) |
| Dilutive (weak company, emergency raise) | -10% to -20%+ |
| Non-dilutive (PE sponsor exit) | -2% to -5% |
| Non-dilutive (founder selling modest amount) | -1% to -3% |
| ATM (small daily amounts) | Minimal impact per day |
The discount at which shares are offered is typically 3-7% below the current market price. Institutional investors require this to absorb a large block quickly without price impact.
Real-World Examples
Alphabet $84.75 Billion Capital Raise (June 2026)
In June 2026, Alphabet (GOOG, GOOGL) announced and priced one of the largest equity capital raises in history. The company sold $18 billion in Class A and Class C common stock plus $16.75 billion in mandatory convertible preferred stock depositary shares, with an additional $40 billion ATM program and $10 billion private placement. Total: $84.75 billion. The stated purpose: scaling AI infrastructure and global compute. This is a textbook dilutive raise from a position of strength. The company is raising capital for a clear, high-growth use of proceeds, and the market received it accordingly.
Rivian $1.32 Billion Offering (July 2026)
In July 2026, Rivian Automotive sold 75 million shares of Class A common stock at $15.50 per share (with underwriters exercising the full over-allotment of 11.25 million additional shares). Net proceeds of approximately $1.32 billion were earmarked for general corporate purposes, including equity contributions related to a Department of Energy loan facility. This is a dilutive raise by a company still working toward sustained profitability. The market context and use of proceeds determine whether investors view this as funding growth or filling a cash gap.
Cytokinetics $805 Million Offering (May 2026)
In May 2026, Cytokinetics (CYTK) closed an underwritten public offering of 11.3 million shares at $71.00 per share, raising approximately $805 million in gross proceeds. All shares were sold by the company (dilutive). The biopharmaceutical firm used the proceeds to advance its cardiovascular drug pipeline following the FDA approval of MYQORZO (aficamten). This is a dilutive raise from a position of strength, funded by a clear clinical and commercial catalyst.
Key Points to Remember
- Dilutive offerings (new shares issued) reduce existing shareholders' ownership percentage and dilute EPS
- Non-dilutive offerings (existing shareholder sales) leave share count unchanged. Proceeds go to the sellers, not the company.
- The market reaction depends heavily on why the offering is occurring. Growth funding is better received than distress financing.
- Offerings are typically priced at a 3-7% discount to market cap price to attract institutional buyers
- ATM (at-the-market) programs allow gradual share sales with minimal daily market impact
- Always determine whether a secondary offering is dilutive (new shares) or non-dilutive (insider selling) before judging the impact on your investment
Common Mistakes to Avoid
- Assuming all secondary offerings are bad: A company raising capital for a genuinely compelling acquisition or debt reduction can be a positive event. Alphabet's $84.75 billion raise in June 2026 was received as a strategic AI infrastructure investment, not a distress signal.
- Ignoring who is selling in a non-dilutive offering: A private equity firm selling shares (planned portfolio exit) is very different from a founder selling because they have lost faith in the company.
- Missing ATM programs: Many companies disclose ATM offerings in footnotes. Ongoing dilution is easy to miss if you only watch for headline offerings.
- Confusing secondary offering with the secondary market: The secondary market is where all stock trading occurs after IPO. A "secondary offering" is a specific additional share issuance event. Completely different concept.
Frequently Asked Questions
Q: Should I sell my shares when a company announces a secondary offering? A: Not automatically. Evaluate the purpose: if the company is raising capital for a compelling acquisition or to fund high-return growth, the dilution may be offset by value creation. If the company is raising capital because it is running out of cash, that is a different story. For non-dilutive insider sales, ask whether insiders are selling a small portion (routine estate/tax planning) or large portions (vote of no confidence).
Q: What is the difference between a secondary offering and a stock buyback? A: They are opposites. A secondary offering increases shares outstanding (diluting ownership). A stock buyback decreases shares outstanding (concentrating ownership). Both can be good or bad depending on the price paid or received relative to intrinsic value. Selling shares at high prices is value-accretive; selling at distressed prices is destructive. Buying back shares at low prices creates value; buying at overvalued prices destroys it.
Q: Can I participate in a secondary offering? A: Institutional investors are typically the buyers in traditional marketed secondary offerings. Retail investors can sometimes participate through their broker if they have access to the IPO/secondary allocation, but most block trades go to large institutions. You can always buy the shares on the open market the morning after the offering at or near the offering price.
